Our in vitro data show that anti-TPO aAbs do exhibit some capacities to destroy NPA thyroid tumour cells by ADCC or CDC but in the present state, cannot be considered as suitable for thyroid cancer immunotherapy. The gene discussed is TPO; the disease is thyroid tumor.